AI GxP validation for regulated life sciences
Compliance

GxP Compliance Checklist 2026: 60 Items Across FDA, EMA, and MHRA That Auditors Actually Check

A practitioner-grade GxP compliance checklist covering 21 CFR Part 11, EU Annex 11/22, data integrity, change control, training, and supplier qualification, with pass/fail criteria auditors use.

Cybroscape Technologies7 min read

Key takeaway

A practitioner-grade GxP compliance checklist covering 21 CFR Part 11, EU Annex 11/22, data integrity, change control, training, and supplier qualification, with pass/fail criteria auditors use.

GxP compliance checklists exist everywhere — and most of them are useless. They list vague principles without pass/fail criteria. They conflate FDA requirements with EU expectations. They skip the items inspectors actually cite in 483 observations. This checklist is different. It covers 60 specific items across eight compliance domains, mapped to the regulation that requires them, with the evidence an inspector expects to see and the failure mode that triggers a finding. Print it, run it quarterly, and close gaps before an inspector finds them.

Domain 1: Electronic records and signatures (21 CFR Part 11 / EU Annex 11)

#Check ItemRegulationEvidence Required
1Unique user IDs — no shared accounts11.10(d), Annex 11 §12.1User admin export showing 1:1 mapping
2Electronic signatures include printed name, date, time, and meaning11.50(a)Screenshot of e-sig record with all four fields
3Password complexity and expiry policy enforced by the system11.300(b)Security config export showing policy parameters
4Audit trail captures who, what, when, why for every record change11.10(e), Annex 11 §9Audit trail extract showing a real change with all four fields
5Audit trails cannot be disabled or modified by users11.10(e)Config showing audit trail is system-enforced, not user-togglable
6Backup and restore procedures tested and documentedAnnex 11 §7.2Most recent backup test report with recovery time
7System access provisioning and deprovisioning tied to HR process11.10(d)Access review log showing deprovisioned leavers
8Session timeout enforced after defined inactivity period11.10(d)System config showing timeout value

FDA 21 CFR Part 11 compliance and EU Annex 11 & Annex 22 readiness are the two regulatory anchors for electronic records. Cybroscape GxP Copilot enforces items 1–5 by design — the hash-chained audit trail cannot be disabled, and electronic signatures capture all four Part 11 fields without configuration.

Domain 2: Data integrity (ALCOA+)

#Check ItemALCOA+ ElementEvidence Required
9All GxP records attributable to a specific individualAttributableRecord sample showing user identity on every entry
10Records are readable and permanently accessible for retention periodLegibleRetention policy + test retrieval of oldest record
11Records created at the time of the activity, not retrospectivelyContemporaneousTimestamp evidence showing entry time matches activity time
12Original records are preserved — no transcription without both versions retainedOriginalData flow map showing original record path
13Records are accurate and verified by a second person where requiredAccurateSecond-person verification evidence on critical records
14Data integrity risk assessment performed for each GxP systemAllCompleted DI risk assessment with scoring
15Periodic data integrity audit programme in placeAllAudit schedule + most recent DI audit report

data integrity (ALCOA+) services cover the full ALCOA+ programme — from initial risk assessment through periodic audit. The hash-chained audit trail in Cybroscape GxP Copilot provides tamper-evident evidence for items 9, 11, and 12 automatically.

Domain 3: Validation lifecycle

  • 16. Validation master plan (VMP) current and approved. Reg: EU GMP Annex 15 §1. Evidence: signed VMP with review date within 12 months.
  • 17. Every GxP system has a current validation status. Reg: GAMP 5. Evidence: system inventory with validation status and next review date.
  • 18. Risk-based approach to validation documented. Reg: FDA CSA guidance, GAMP 5 SE. Evidence: risk assessment per system showing how testing depth was determined.
  • 19. Traceability matrix links requirements → tests → results. Reg: GAMP 5. Evidence: RTM for each validated system showing complete coverage.
  • 20. Periodic review programme in place. Reg: EU GMP Annex 11 §11. Evidence: review schedule + most recent periodic review report.
  • 21. Change control procedure covers all validated systems. Reg: ICH Q10, GAMP 5. Evidence: change control SOP + log of recent changes with impact assessments.
  • 22. Decommissioning procedure exists for retiring validated systems. Reg: Annex 11 §11. Evidence: decommissioning SOP + evidence of data migration or archival.

Cybroscape GxP Copilot generates the validation package — URS, risk assessment, IQ/OQ/PQ protocols, Live RTM, and Validation Summary Report — for items 16–19. Change controls handles item 21 with full audit trail and impact assessment workflows.

Domain 4: Change control and configuration management

  • 23. Change control SOP defines categories (minor, major, emergency). Evidence: SOP with category definitions and approval matrices.
  • 24. All changes risk-assessed before implementation. Evidence: change records with completed impact assessments.
  • 25. Regression testing performed for major changes. Evidence: test records linked to change control records.
  • 26. Emergency changes documented retrospectively within defined timeframe. Evidence: emergency change records with retrospective documentation within SOP-defined window.
  • 27. Configuration items baselined and version-controlled. Evidence: configuration baseline document + change history.
  • 28. Vendor patches assessed for GxP impact before deployment. Evidence: patch assessment records showing GxP impact analysis.

Domain 5: Training and competency

  • 29. Training matrix covers all GxP roles and required SOPs. Evidence: current training matrix with role-to-SOP mapping.
  • 30. Training completed before performing GxP activities. Evidence: training records with completion dates before first activity date.
  • 31. Training effectiveness assessed (not just attendance). Evidence: competency assessments (quiz, observation, practical) with pass/fail criteria.
  • 32. Retraining triggered by SOP revisions. Evidence: SOP revision log cross-referenced with retraining records.
  • 33. Training records maintained for retention period. Evidence: oldest training record retrievable within the defined retention window.
  • 34. Annual training gap analysis performed. Evidence: most recent gap analysis report with remediation actions.

Domain 6: Supplier and vendor qualification

  • 35. Approved supplier list maintained and current. Evidence: ASL with qualification status and review dates.
  • 36. GxP software vendors audited or assessed before use. Evidence: vendor audit reports or questionnaire assessments.
  • 37. Quality agreements in place for GxP-critical suppliers. Evidence: signed quality agreements with defined responsibilities.
  • 38. SaaS/cloud vendor shared responsibility model documented. Evidence: shared responsibility matrix per cloud vendor.
  • 39. Supplier performance monitored periodically. Evidence: supplier scorecard or performance review records.
  • 40. Supplier change notifications received and assessed. Evidence: notification log with impact assessments for recent changes.

supplier qualification and cloud & SaaS validation services cover items 35–40, including the shared responsibility model documentation that cloud and SaaS deployments require.

Domains 7 and 8: Deviation/CAPA management and documentation control

  • 41–45: Deviations. All deviations documented within defined timeframe. Root cause investigation performed for major deviations. CAPA assigned, tracked, and verified for effectiveness. Repeat deviations trigger trend analysis. CAPA closure verified by QA.
  • 46–50: Documentation. All GxP documents version-controlled. Obsolete documents removed from point of use. Document review cycle defined and followed. Distribution controlled and acknowledged. Retention periods defined and enforced.
  • 51–55: Facilities and equipment. Equipment qualification current (IQ/OQ/PQ). Calibration programme in place with defined schedules. Preventive maintenance programme documented. Environmental monitoring where required. Cleaning validation current.
  • 56–60: Management review. Annual product quality review performed. Management review of quality system conducted. KPIs defined and tracked. Internal audit programme in place with trained auditors. Regulatory intelligence programme monitors guidance changes.

This checklist is not exhaustive — individual regulatory submissions, clinical operations, and manufacturing processes carry additional requirements. But these 60 items represent the core compliance posture that every GxP organisation must maintain. Run the checklist quarterly. Close gaps within 30 days. Track closure rates as a leading indicator of inspection readiness. audit readiness provides the mock-audit protocol that tests these items under realistic inspection conditions.

Where to go next

Explore Cybroscape GxP Copilot for AI-native validation, Cybroscape TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.

Part of our guide to GxP software — categories, evaluation criteria and how the platforms compare. For the detail on this specifically, see what GxP is.

One evidence baseValidation, data integrity, change control
FDAEMAMHRAPMDACDSCOHealth CanadaTGASwissmedic
Regulators differ in emphasis, not in what a defensible record is. One evidence base built to the strictest applicable expectation, with each regulator's specific points mapped onto it, avoids running a separate validation approach per market.
See it on your own systemBring a URS or a system. We run GxP Copilot against it live on the call.
gxp compliance checklistgxp compliance requirementsgxp audit checklistfda gxp compliance checklistpharma compliance checklist 2026

Keep reading

All articles
Audit ReadinessHow to Prepare for a GxP Audit: A Practical ChecklistWhat a GxP audit examines, how to prepare in the weeks before, the evidence auditors ask for first, the findings that recur most often, and how to answer questions you do not know the answer to. · 8 min readCompliancePeriodic Review: The Annex 11 Obligation Almost Everyone Is Behind OnPeriodic review is required, routinely overdue, and the fastest way for an inspector to find out that a validated estate stopped being validated. What it is, what it is not, and how to catch up. · 5 min readComplianceWhat Is GxP? A Plain-English Guide to GMP, GLP and GCPGxP explained without the jargon: what the letters mean, which rules apply to which work, who enforces them, and what "being GxP compliant" actually requires of a system or a team. · 8 min readComplianceGxP Archiving and Data Retention: The Complete Compliance GuideEverything regulated teams need to know about GxP archiving: retention periods by record type, regulatory requirements, format obsolescence, migration, and the difference between archiving and backup. · 8 min readComplianceGxP Compliance in the Pharmaceutical Industry: A 2026 Practitioner's GuideEverything a quality or validation professional needs to know about GxP compliance in pharma: the regulatory framework, the practical requirements, and where most companies fall short. · 7 min readComplianceGxP Risk Assessment: Deciding What Actually Needs ValidatingHow to run a defensible GxP risk assessment: determining GxP impact, scoring severity and detectability under ICH Q9, and using the result to set validation effort instead of validating everything equally. · 7 min readComplianceGxP Roles and Responsibilities: Who Signs What, and WhyThe roles a GxP system depends on (process owner, system owner, QA, IT, validation lead): what each is accountable for, why separation of duties matters, and the handover gaps that cause findings. · 7 min readComplianceGxP vs GMP vs GLP vs GCP: What Each One Actually CoversA side-by-side breakdown of the GxP disciplines: what each regulates, where they overlap, which one applies to your work, and the boundary mistakes that create audit findings. · 8 min read

Bring a system. We'll show you the package.

Book a demo, or ask a validation lead a quick question on WhatsApp.

  • We reply within one business day
  • We run your URS live on the call
  • You get a clear plan for your system
Chat on WhatsApp

Book a demo

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.